AZN vs PRSO · P/E 28, $288.38B cap vs rev $2.3M
AstraZeneca PLC (AZN) versus Peraso Inc (PRSO) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Peraso Inc (PRSO) is a semiconductors company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported PRSO revenue for 2026-06-30 was $2.3M. Net income was -$4.7M. PRSO currently screens at market cap $13.1M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PRSO currently screens at market cap $13.1M.
Not investment advice. Open the AZN and PRSO stock pages for the full models.
Not investment advice.